DEXCOM INC. DL-,001/ US2521311074 /
2024-05-17 8:55:15 PM | Chg. -0.26 | Volume | Bid10:00:01 PM | Ask10:00:01 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
120.02EUR | -0.22% | 223 Turnover: 26,934.58 |
120.54Bid Size: 50 | 121.16Ask Size: 50 | 48.07 bill.EUR | - | - |
GlobeNewswire
04-08
Precision Neuroscience Names Verily Co-Founder Brian Otis as Chief Technology Officer
GlobeNewswire
01-31
Trinity Biotech Announces Acquisition of the CGM Assets of Waveform Technologies, Inc.